乐琬琪, 廖景瑜, 张榆浩, 吴高松, 张卫东. 肠道菌群作为中药治疗心血管疾病的靶标: 潜在的机制和治疗策略J. 药学学报, 2023, 58(8): 1988-1999. DOI: 10.16438/j.0513-4870.2023-0261
引用本文: 乐琬琪, 廖景瑜, 张榆浩, 吴高松, 张卫东. 肠道菌群作为中药治疗心血管疾病的靶标: 潜在的机制和治疗策略J. 药学学报, 2023, 58(8): 1988-1999. DOI: 10.16438/j.0513-4870.2023-0261
LE Wan-qi, LIAO Jing-yu, ZHANG Yu-hao, WU Gao-song, ZHANG Wei-dong. Gut microbiota as a target for traditional Chinese medicine in the treatment of cardiovascular disease: potential mechanisms and therapy strategiesJ. Acta Pharmaceutica Sinica, 2023, 58(8): 1988-1999. DOI: 10.16438/j.0513-4870.2023-0261
Citation: LE Wan-qi, LIAO Jing-yu, ZHANG Yu-hao, WU Gao-song, ZHANG Wei-dong. Gut microbiota as a target for traditional Chinese medicine in the treatment of cardiovascular disease: potential mechanisms and therapy strategiesJ. Acta Pharmaceutica Sinica, 2023, 58(8): 1988-1999. DOI: 10.16438/j.0513-4870.2023-0261

肠道菌群作为中药治疗心血管疾病的靶标: 潜在的机制和治疗策略

Gut microbiota as a target for traditional Chinese medicine in the treatment of cardiovascular disease: potential mechanisms and therapy strategies

  • 摘要: 心血管疾病(cardiovascular disease, CVD) 是全球范围内造成患者死亡的主要因素, 其发病机制复杂且死亡率逐年增高。大量研究显示, 肠道菌群及其代谢产物与心血管疾病的发生发展密切相关, 肠道菌群有望成为治疗心血管疾病潜在的新靶点。中药具有多组分、多靶点和整体性的特点, 可通过调控肠道菌群发挥对心血管疾病的治疗作用, 在稳定病情、改善心脏功能、提高生活质量等方面具有明显的优势, 是一种理想的肠道微生态调节剂。因此, 本综述将主要讨论肠道菌群及其代谢产物与心血管疾病的密切关联, 中药靶向肠道菌群改善心血管疾病的治疗策略, 包括调节肠道菌群组成、保护肠道黏膜屏障、影响肠道免疫功能和调控肠道菌群代谢产物, 为中药靶向肠道菌群治疗心血管疾病的研究提供参考。

     

    Abstract: Cardiovascular disease (CVD) is a major contributor to patient deaths worldwide, and its pathogenesis is complex and mortality rates are increasing every year. Numerous researches have shown that the gut microbiota and its metabolites were closely associated with the development of CVD, and gut microbiota was expected to be a potential new target for the treatment of CVD. Traditional Chinese medicine (TCM), characterized by its multi-component, multi-target and integrity, can play a therapeutic role in CVD by regulating the gut microbiota, which has obvious advantages in stabilizing the disease, improving heart function and enhancing quality of life, and is an ideal intestinal microecological regulator. Therefore, this review will mainly discuss the intimate association of gut microbiota and its metabolites with CVD, and the therapeutic strategies of TCM targeting gut microbiota to improve CVD, including regulating the composition of gut microbiota, protecting the intestinal mucosal barrier, influencing the intestinal immune function and modulating the metabolites of gut microbiota, in order to provide a reference for the research of TCM targeting gut microbiota for CVD.

     

/

返回文章
返回